DiabetologyNews.net

Diabetology Xagena

Search results for "Liraglutide"

Liraglutide ( Victoza ) once daily is substantially better at controlling blood glucose in type 2 diabetes than is twice-daily Exenatide ( Byetta ). These are the findings of the LEAD-6 study.Liraglut ...


The EMA ( European Medicines Agency ) is investigating findings by a group of independent academic researchers that suggest an increased risk of pancreatitis ( inflammation of the pancreas ) and preca ...


Glucagon-like peptide-1 receptor agonists Exenatide ( Byetta ) and Liraglutide ( Victoza ) have been shown to improve glycaemic control and reduce bodyweight in patients with type 2 diabetes.The effic ...


The results from SUSTAIN-1, the first phase 3a trial for Semaglutide, a new GLP-1 analogue administered once-weekly were presented. The trial investigated the efficacy and safety of 0.5 mg and 1.0 m ...